Delivery Order SPE2DR25D1109-SPE2DR26FFF5Z
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,713.54 by the Defense Logistics Agency on October 23, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. The contract represents a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens (0.5 mL) with an ultimate completion date of June 2, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The company serves as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $3,392.79 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pens on August 15, 2025, with completion expected by August 18, 2025. This firm fixed price, non-set-aside delivery order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs,...
- The Defense Logistics Agency awarded a $2,955.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for supply of Mounjaro 7.5 mg/0.5 mL pens on July 15, 2025, with completion targeted for July 16, 2025. This non-set-aside delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,088.36 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pens, with a completion date of October 28, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of the company's substantial pharmaceutical supply role within the federal healthcare system. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and...
- The Defense Logistics Agency awarded a delivery order valued at $4,760.40 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pens on September 18, 2025, with completion scheduled for September 19, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive procurement for pharmaceutical supplies to support federal medical needs. The award was made to AmerisourceBergen's corporate office, with performance occurring at the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,900.39 for Mounjaro 2.5 mg/0.5 ml pens on September 24, 2025, with completion scheduled for September 25, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded pharmaceutical supply transaction supporting federal medical procurement needs. The award is issued to the Conshohocken, Pennsylvania-based corporate office of AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,632.54 for Mounjaro 12.5 mg/0.5 ml pen units on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order for pharmaceutical supplies to support federal medical procurement needs. The award was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9...
- The Defense Logistics Agency awarded a delivery order valued at $2,586.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order is non-competitive and utilizes a competitively awarded indefinite delivery contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. As a major...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFF5ZDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,460.82 for Mounjaro 7.5 mg/0.5 mL pens on October 27, 2025, with final completion required by October 28, 2025. This competitively awarded, firm fixed-price order represents a small-value pharmaceutical delivery supporting federal medical procurement needs. The award was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, has demonstrated substantial capability in fulfilling federal medical supply requirements through consistent competitively awarded contracts with the DLA. The company supplies an extensive portfolio of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices serving customers including the Defense Health Agency and U.S. Coast Guard. This delivery order reflects the company's critical role within the federal medical supply chain and its ability to meet urgent pharmaceutical requirements for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 10/27/25 |